Investors

Directorate Change

LONDON, 3 June 2009 - Optos plc (LSE: OPTS), a leading retinal imaging Company, today announces that Allan Watson has informed the Board that he intends to step down from his role as Chief Financial Officer and leave the Company in due course. Allan is to join ProStrakan Group plc, the international specialty pharmaceutical company, as Chief Financial Officer.

Optos's Chairman, Dr John Padfield, said: "On behalf of the Board I would like to thank Allan for the excellent contribution he has made to the business. Since joining the Company in 2003 Allan has contributed widely to the strategic development of Optos including his role in steering the Company through its IPO and, for a period, as interim CEO. We all wish him well as he develops his career".

A recruitment process for a new Chief Financial Officer is underway and a further announcement will be made once the process of an orderly handover has been concluded.

< ENDS >

Enquiries

Optos Roy Davis, Chief Executive	+44 (0)1383 843316
Maitland Neil Bennett Brian Hudspith	+44 (0)20 7379 5151

About Optos Plc

Optos plc is a leading retinal imaging company with a vision to be recognised as the leading provider of retinal diagnostics through leveraging its unique wide-field imaging technology. The company has built an extensive installed base for its technology among healthcare professionals under its pay-per-patient business model. This provides an excellent position from which to focus on its core optometry business and expand into ophthalmology in a measured way.

For more information please visit our website www.optos.com